Biotechnology News

April 21, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s refiling of two New Drug Applications (NDA) for cobicistat, a pharmacoenhancing...

April 21, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) will webcast its annual meeting of shareholders on Tuesday, May 6, 2014 at 9:00 a.m. Central Time. This meeting is being webcast by Nasdaq OMX and can be accessed along with...

April 21, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) will release its first quarter 2014 financial results on Thursday, May 1, 2014 after the markets close. The announcement will be followed by a live conference call and...

April 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) today announced that it has commenced an underwritten public offering of 2,000,000 shares of its common stock. All of the shares in the offering are to be sold by Agios...

April 21, 2014

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ:IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its first quarter ended March 31...

April 21, 2014

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $63.3 million for the first...

April 21, 2014

PLYMOUTH, Mich.--(BUSINESS WIRE)--ProNAi Therapeutics Raises $59.5 Million Series D Financing. Proceeds Will Advance Clinical Studies of Its BCL2 Targeted Cancer Drug and Other Pipeline Candidates.

April 21, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) (“the Company” or “RegeneRx”) today announced that it has received a Notice of Allowance for a second U.S. patent for treating central nervous system injuries and...

April 21, 2014

NEWTON, Mass.--(BUSINESS WIRE)--Are providers ready for collaborative clinical and financial decisions at the point of care? McKesson Health Solution’s Holly Toomey will answer that question and more at this year’s Dorland Health 6th Annual Care...

April 21, 2014

EDMONTON, Alberta--(BUSINESS WIRE)--Extraordinary teenage scientists from 6 schools in Edmonton and Calgary will compete for top honors on April 28 in the regional “2014 Sanofi BioGENEius Challenge Canada (SBCC)”, a national biotechnology...

April 21, 2014

SKANEATELES FALLS, N.Y.--(BUSINESS WIRE)--Welch Allyn has again been named to the top 100 list of “The Best Companies to Work For” in Mexico, the country’s most comprehensive study of workplace culture.

April 21, 2014

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD announced the addition of Bhooshi De Silva as senior vice president of corporate development and strategy to its executive leadership team.

April 21, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Atlantic Research Group, Inc. (ARG) has implemented Comprehend Clinical for clinical data insights, enabling ARG to improve clinical operations and increase trial effectiveness.

April 21, 2014

WASHINGTON--(BUSINESS WIRE)--A selective group of CEOs and COOs from emerging industrial biotechnology companies will present new technologies and business cases during the Clean Tech Investor Sessions at 2014 BIO World Congress.

April 21, 2014

WASHINGTON--(BUSINESS WIRE)--DIA 2014 50th Annual Meeting to Explore Regulatory Challenges for Orphan Medicines. Symposium to highlight how legislation in Europe and U.S. can help bring medicines to market.

April 21, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced promising preclinical results for RX-21101...

April 21, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences introduces IsoFlux™ NGS assay kits for circulating biomarker detection.
New kits enable mutation detection from circulating tumor cells using next-generation sequencing.

April 21, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation, leading provider of technologies used to collect patient-driven eData for clinical research, promoted Vice President of Service Delivery Andrea Valente to Chief Operating Officer.

April 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven will be presenting at 3 ophthalmology industry conferences in the coming weeks including a discussion with experts on dry eye disease and preclinical data on EBI-029 for DME.

April 21, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist submitted New Drug Application to FDA for approval of investigational antibiotic ceftolozane/tazobactam for treatment of complicated urinary tract and complicated intra-abdominal infections.

April 21, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter results will be released on Thursday, May 1 2014, after the close of the stock market. The company will host a conference call and webcast...

April 21, 2014

COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--CSHL President Dr. Bruce Stillman is the 2014 winner of the Herbert Tabor Research Award for excellence in biological chemistry and molecular biology and for contributions to the scientific community.

April 21, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals, announced today that it has produced more than one metric ton of bio-based dodecanedioic acid (DDDA)...

April 21, 2014

BEDFORD, Mass--(BUSINESS WIRE)--Ocular Therapeutix, developers of a proprietary hydrogel technology, announce 11 podium and poster presentations, including its ReSure Sealant and sustained release dexamethasone, at ASCRS Boston.

April 21, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, today announced the publication of an overview of lysosomal acid lipase...

April 21, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals will be presenting at the RedChip Global Online CEO Conference on April 24, 2014.

April 21, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BioThrax® (Anthrax Vaccine Adsorbed) for post-exposure prophylaxis (PEP...

April 21, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer

April 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-based therapeutics, today announced it plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) by the...

April 21, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Appoints Jean S. Campbell, Ph.D. as Executive Director of Research and Development

April 21, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, Inc. (www.kinemed.com) announced participation in a global, two year, multi-organization effort to advance and standardize a single mouse...

April 21, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus' PV-10 Clinical Data on The Treatment of Melanoma to be Presented at the 10th European Association of Dermato-Oncology (EADO) Congress in Vilnius, Lithuania.

April 21, 2014

BROOMFIELD, Colo.--(BUSINESS WIRE)--Penn Pharma Staff Complete Potent Compound Safety Training Certification through Affygility Solutions.

April 18, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that it granted stock options to Pankaj Bhargava, M.D., the Company’s chief medical officer,...

April 18, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 8:30 a.m. (Eastern Daylight Time) on Thursday, April 24. To access the webcast, visit our website at...

April 18, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials
Due to Presence of Particulate Matter

April 18, 2014

WASHINGTON--(BUSINESS WIRE)--Pioneers in Regenerative Therapy to Discuss New Trends in Stem Cell Medicine; International leaders to share unparalleled achievements in stem cell research at DIA Annual Meeting

April 18, 2014

GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapies announced today that it presented preclinical data in two poster...

April 18, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Tech Council of Maryland hosts Maryland gubernatorial candidates in forum to discuss issues impacting tech and life sciences sectors in the state.

April 18, 2014

SAN DIEGO--(BUSINESS WIRE)--Bioserv Corporation, a contract manufacturer of injectable pharmaceuticals and medical devices, is pleased to announce the appointment of Jay Schrier, Ph.D., as Senior Vice President of Pharmaceutical Technologies. Dr...

April 17, 2014

--(BUSINESS WIRE)--Vince & Associates Clinical Research:                   Who: Guest of Honor - Overland Park, KS Mayor, Carl Gerlach   What: Vince & Associates Clinical Research will host a ceremony to mark the groundbreaking of the new...

April 17, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today announced that the U.S. Food and Drug Administration has approved RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (12 Amb a 1-U).

April 17, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea provided updates on several programs and events relating to Lymphoseek including a head-to-head clinical study underway at the UCSD.

April 17, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call...

April 17, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion announced the appointment of John “Jack” T. Mollen to its Board of Directors. The Company also announced that Joseph A. Madri, Ph.D., M.D. and Larry L. Mathis, will retire on May 5, 2014.

April 17, 2014

NEEDHAM, Mass.--(BUSINESS WIRE)--Bio-IT World announced that its 13th annual conference and expo, to be held April 29-May 1 at the Seaport World Trade Center in Boston, will debut a new disciplinary track focused on Data Security.

April 17, 2014

NEEDHAM, Mass.--(BUSINESS WIRE)--Medical Informatics World Conference announced it will debut a new disciplinary track focused on information security and privacy in healthcare.

April 17, 2014

WASHINGTON--(BUSINESS WIRE)--Innovative Blue Button Project to Be Discussed at DIA 2014 50th Annual Meeting; Session will explore state-of-the-art initiative allowing patients to access their individual data

April 17, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Paris:MKEA) (Euronext: MKEA, FR0010609263), leader in the Optical Biopsy market, announced today major progress in the adoption of Optical Biopsy around the world. While more than...